Financhill
Sell
40

BUSE Quote, Financials, Valuation and Earnings

Last price:
$21.69
Seasonality move :
0.4%
Day range:
$21.53 - $22.31
52-week range:
$21.21 - $28.97
Dividend yield:
4.47%
P/E ratio:
11.01x
P/S ratio:
2.70x
P/B ratio:
0.89x
Volume:
421.1K
Avg. volume:
528.8K
1-year change:
-9.81%
Market cap:
$1.2B
Revenue:
$461.4M
EPS (TTM):
$1.97

BUSE Analysts' Consensus Rating

The 3 analysts providing 12-month price projections for First Busey shares anticipate an average target of $28.17, ranging from a low estimate of $25.00 to a high estimate of $33.00. This average target implies a growth of 29.86% compared to the current stock price of $21.69.

Consensus Price Target

$28.17

Highest Price Target

$33.00

Lowest Price Target

$25.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 2 1 1

Hold 1 2 2

Sell 0 0 0
Consensus Buy Hold Hold

BUSE Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is it Finally Time to Buy Medical Properties Trust?
Is it Finally Time to Buy Medical Properties Trust?

Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…

Why Did Signet Jewelers Stock Go Up So Much?
Why Did Signet Jewelers Stock Go Up So Much?

Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…

Why Did HealthEquity Stock Fall So Much?
Why Did HealthEquity Stock Fall So Much?

HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
AJINY alert for Mar 29

Ajinomoto [AJINY] is up 99.61% over the past day.

Buy
85
SLNO alert for Mar 29

Soleno Therapeutics [SLNO] is up 6.8% over the past day.

Buy
69
AGX alert for Mar 29

Argan [AGX] is up 19.83% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock